Dr Dale Morrison Awarded a BreakthroughT1D Early Career Research Fellowship
We are proud to announce that our research fellow Dr Dale Morison has been awarded Early Career Basic Researcher Fellowship for 2026!
The Breakthrough T1D Australia Type 1 Diabetes Clinical Research Network (T1DCRN) have awarded 7 researchers the Early Career Basic Researcher Fellowships to Australian Researchers in the T1D space. These fellowships support the development of the best and brightest emerging researchers in Australia who can accelerate world-class research out of the lab and into the hands of people living with T1D. Each Fellow has been awarded $150,000 over 2 years, which also supports a bespoke mentorship plan with tailored training and career development opportunities to foster their independence as researchers. These fellowships aim to boost the talents of the next generation of upcoming leaders in Australian T1D research to secure more breakthroughs in T1D science in future years.
Dale’s research project aims to determine if lactic acid (lactate), which is produced when glucose is broken down without oxygen, can be used to characterise insulin resistance in people with T1D. Insulin resistance is a risk factor for T1D complications like heart and blood vessel damage. New devices, called continuous lactate monitors, are similar to (and can be incorporated into) widely used continuous glucose monitors. If lactate is a predictor of insulin resistance, these monitors may be a simple way to identify individuals at risk of T1D complications, so they can be treated early.
Dr Dale Morrison Awarded a BreakthroughT1D Early Career Research Fellowship
We are proud to announce that our research fellow Dr Dale Morison has been awarded Early Career Basic Researcher Fellowship for 2026!
The Breakthrough T1D Australia Type 1 Diabetes Clinical Research Network (T1DCRN) have awarded 7 researchers the Early Career Basic Researcher Fellowships to Australian Researchers in the T1D space. These fellowships support the development of the best and brightest emerging researchers in Australia who can accelerate world-class research out of the lab and into the hands of people living with T1D. Each Fellow has been awarded $150,000 over 2 years, which also supports a bespoke mentorship plan with tailored training and career development opportunities to foster their independence as researchers. These fellowships aim to boost the talents of the next generation of upcoming leaders in Australian T1D research to secure more breakthroughs in T1D science in future years.
Dale’s research project aims to determine if lactic acid (lactate), which is produced when glucose is broken down without oxygen, can be used to characterise insulin resistance in people with T1D. Insulin resistance is a risk factor for T1D complications like heart and blood vessel damage. New devices, called continuous lactate monitors, are similar to (and can be incorporated into) widely used continuous glucose monitors. If lactate is a predictor of insulin resistance, these monitors may be a simple way to identify individuals at risk of T1D complications, so they can be treated early.